Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.33	26.14	9.7	0.46	16.58	-
Cash & Short-Term Investments	22.33	26.14	9.7	0.46	16.58	-
Cash Growth	-46.56%	169.48%	2032.09%	-97.26%	-	-
Prepaid Expenses	6.36	3.87	3.37	2.03	1.71	-
Other Current Assets	0.84	0.94	0.33	0.16	0.13	0.2
Total Current Assets	29.53	30.95	13.4	2.64	18.41	0.2
Property, Plant & Equipment	0.47	0.72	0.79	0.17	0.33	-
Total Assets	30	31.67	14.19	2.82	18.74	0.2
Accounts Payable	0.78	1.06	0.84	0.89	0.74	0.18
Accrued Expenses	2.17	3.56	3.23	2.24	1.21	0.18
Short-Term Debt	-	-	-	-	-	2.51
Current Portion of Leases	0.41	0.56	0.33	0.16	0.15	-
Other Current Liabilities	10.21	18.94	13.13	-	-	-
Total Current Liabilities	13.57	24.12	17.53	3.28	2.11	2.88
Long-Term Leases	-	0.12	0.47	-	0.16	-
Total Liabilities	13.57	24.24	18	3.28	2.26	2.88
Common Stock	0.12	0.11	0.04	0.02	0.02	0.01
Additional Paid-In Capital	123.45	108.59	60.7	33.52	32.41	3.24
Retained Earnings	-107.15	-101.27	-64.54	-34	-15.94	-5.92
Shareholders' Equity	16.43	7.43	-3.81	-0.47	16.48	-2.67
Total Liabilities & Equity	30	31.67	14.19	2.82	18.74	0.2
Total Debt	0.41	0.68	0.79	0.16	0.31	2.51
Net Cash (Debt)	21.92	25.46	8.91	0.3	16.27	-2.51
Net Cash Growth	-46.73%	185.82%	2869.33%	-98.16%	-	-
Net Cash Per Share	2.02	3.80	3.63	0.20	13.94	-2.96
Filing Date Shares Outstanding	17.66	11.97	3.48	1.52	1.5	0.89
Total Common Shares Outstanding	14.11	11.38	3.48	1.52	1.5	0.85
Working Capital	15.96	6.83	-4.14	-0.64	16.31	-2.67
Book Value Per Share	1.16	0.65	-1.10	-0.31	10.99	-3.14
Tangible Book Value	16.43	7.43	-3.81	-0.47	16.48	-2.67
Tangible Book Value Per Share	1.16	0.65	-1.10	-0.31	10.99	-3.14
Machinery	0.07	0.06	0.02	0.01	0.01	-
Construction In Progress	-	0.01	-	-	-	-
Leasehold Improvements	0.06	0.05	0.02	0.02	0.02	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q